Usha Devi S.
Mira Vala
- Associate Professor Murlidhar College of Nursing Gujarat India
- Student Murlidhar College of Nursing Gujarat India
Abstract
The World Health Organization (WHO) advocates for the inclusion of the human papilloma virus (HPV) vaccine in standard immunization schedules worldwide, in addition to other preventive strategies. The launch of the prophylactic HPV vaccine has markedly improved primary prevention measures against cervical cancer and other diseases caused by HPV. Following their approval in 2006, both the quadrivalent and bivalent HPV vaccines have received authorization in over 100 countries. As of the start of 2012, the HPV vaccine was incorporated into the national vaccination schedules of a minimum of 40 countries worldwide. The vaccine regimen consists of two or three doses, depending on the recipient’s age and immune function. Despite vaccination, cervical cancer screening remains essential. Widespread vaccination not only protects vaccinated individuals but also confers indirect benefits to those not vaccinated. The HPV vaccines are considered highly safe, though common side effects, affecting about 80% of recipients, include pain, redness at the injection site, and fever. The main purpose of the HPV vaccine is to provide protection against cervical cancer. It has also been shown to block almost 100% of the precancerous changes in cervical cells linked to HPV types 16 and 18. According to available information, the duration of protection for Cervarix extends up to 6.4 years, while for Gardasil, it lasts up to 5 years in women who tested negative for HPV at the moment of vaccination. The present pre-experimental one group pretest and posttest research design was conducted among women to evaluate the effectiveness of HPV vaccine for prevention of cervical cancer. The researcher selected 60 samples based on nonprobability sampling technique. The findings indicated that knowledge levels improved following the implementation of a structured teaching program, demonstrating its effectiveness. The researcher concluded that, the teaching aids will be helpful in improving knowledge among women as well as public. The researcher recommended that, the community education program and personal behavior change education is required for bring awareness regarding HPV vaccine for prevention of cervical cancer.
Keywords: Human papilloma virus vaccine, cervical cancer, women, sampling technique, immune response
[This article belongs to International Journal of Oncological Nursing and Practices(ijonnp)]
References
- HPV Vaccine. [Online]. Available at https://en.m.wikipedia.org/wiki/HPV_vaccine
- The history of the HPV vaccine. [Online]. June 18, 2020. Available athttps://www.nomancampaign.org/post/the-history-of-the-hpv-vaccine
- National Cancer Institute. Human papillomavirus (HPV) vaccines. [Online]. May 25, 2021. Available athttps://www.cancer.gov/cancertopics/factsheet/risk/hpvvaccine
- Abushaikha L, Edwards JE, Cesario S. “Moms and babies first” – a historical overview of the Association of Women’s Health Obstetric and Neonatal Nurses. Nurs Outlook. 2021; 69 (6): 1049– doi: 10.1016/j.outlook.2021.05.012.
- World Health Organization. Human papillomavirus vaccines: WHO position paper, May 2017. Wkly Epidemiol Rec. 2017; 92 (19): 241–2 English, French.
- D’Oria O, Corrado G, Laganà AS, Chiantera V, Vizza E, Giannini A. New advances in cervical cancer: from bench to bedside. Int J Environ Res Public Health. 2022; 19 (12): doi: 10.3390/ijerph19127094.
- Park K. Park’s Textbook of Preventive & Social Medicine.Jabalpur, India: Banarsidas Bhanot Publishers; 2021.
- Saqer A, Ghazal Sh, Barqawi H, Babi JA, AlKhafaji R, Elmekresh MM. Knowledge and awareness about cervical cancer vaccine (HPV) among parents in Sharjah. Asian Pac J Cancer Prev. 2017; 18 (5): 1237– doi: 10.22034/APJCP.2017.18.5.1237.
- Mehta S, Rajaram S, Goel G, Goel N. Awareness about human papilloma virus and its vaccine among medical students. Indian J Community Med. 2013; 38 (2): 92-9 doi: 10.4103/0970-0218.112438.
- Loukissas J. Differences in knowledge of HPV and the HPV vaccine by education, race, and ethnicity. [Online]. Division of Cancer Epidemiology & Genetics at the National Cancer Institute. November 22, 2023. Available at: https://dceg.cancer.gov/news-events/news/2023/education-race-hpv-awareness
| Volume | 02 |
| Issue | 01 |
| Received | April 19, 2024 |
| Accepted | May 6, 2024 |
| Published | May 16, 2024 |